Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Chugai

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Chugai's Japan sales performance.

Chinese biotechs aim PD-L1 antibody at hepatitis B

Chinese biotechs aim PD-L1 antibody at hepatitis B

Suzhou Alphamab is already testing its PD-L1 inhibitor antibody KN035 in a number of clinical trials across tumour types in the US, China and Japan, but has licensed rights for

Relearning launch: Four key dynamics for pharma launches in 2019

Relearning launch: Four key dynamics for pharma launches in 2019 Japan is recalibrating its traditional national quantitative approach to care decisions with a new regional approach to qualitative health and quality-of-life targets.

Ashfield joins forces with Argon Global Healthcare Network

Ashfield joins forces with Argon Global Healthcare Network Doug Burcin, President, Ashfield Healthcare Communications. “We have a well-established presence in the UK, Germany, Japan and US for delivering our solutions at the intersection of science, data and creativity

Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMO

Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMO inflammation test for managing asthma, across key markets such as the United States, China, and Japan, as well as the rest of the world.

Chugai gains FDA breakthrough status for rare CNS treatment

Chugai gains FDA breakthrough status for rare CNS treatment Adds to company's BTD roll-call. The FDA has granted Breakthrough Therapy Designation to Chugai’s satralizumab, a treatment currently in phase 3 for the rare CNS disorders neuromyelitis optica ... Satralizumab is a recycling antibody created via

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Ashfield

Ashfield, part of UDG Healthcare plc, is a global leader in commercialisation services for the healthcare industry. We partner with...

Latest intelligence

The new UK government-pharma industry pricing agreement – welcome news, but there are lessons to be learnt
...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again – in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics